Top of the morning to you. Another shiny day is unfolding here on the Pharmalot corporate campus, where the birds are chirping, the air is crisp and the short people are adhering to their schoolhouse schedule. To celebrate such good fortune, we are quaffing a delicious cup of stimulation. Nonetheless, there is much to do. We know you can relate. After all, the workload never ends, does it? So here are a few items to peruse. Hope you achieve your goals today. And do stay in touch...
AmerisourceBergen To Buy Specialty Drug Transporter (Philadelphia Business Journal)
For Sale: Securities Backed By Royalties On Pharma Patents (Reuters)
Two Biotech Stocks Surge As Seeking Alpha Writer Questioned (The Street)
Roche Has Other Options If Illumna Hostile Bid Fails (Bloomberg News)
Pfizer Revamps Recruitment For Virtual Clinical Trial (Outsourcing Pharma)
Connecticut Docs Disciplined But Also On Pharma Payroll (Middletown Press)
AstraZeneca Weighs Options For Indian Unit (The Independent)
Ranbaxy Launches Lipitor In Four EU Markets (Reuters)
EDITOR'S NOTE: Please check this post for updates throughout the morning
sunrise pic thx to benimoto on flickr





